Clinical Trials Browser

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT07514715 2026-04-13

RT4

Not yet recruiting

129 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT07524114 2026-04-13

SHERLOCK

Recruiting

7,000 enrolled

BreastDermatologicGastrointestinalHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Urogenital Neoplasms, Neoplasm, Residual

NCT05479708 2026-04-08

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Active not recruiting

150 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT06875609 2026-03-30

ctDNA in Cutaneous Squamous Cell Carcinoma

Recruiting

60 enrolled

Dermatologic

Skin Neoplasms, Neoplasm, Residual

NCT07500441 2026-03-30

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Recruiting

100 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07483476 2026-03-19

CIRCALL

Not yet recruiting

205 enrolled

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

HER2 CR

RT4

SHERLOCK

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

ctDNA in Cutaneous Squamous Cell Carcinoma

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

CIRCALL